| 30.09.2025 18:12 | HUI, GRL, FAIR | EARNINGS: Caledonian widens annual loss; Fair Oaks dividend unchanged | Alliance |
| 30.09.2025 07:00 | EMVC | Interim Results and Investor Presentation | RNS |
| 23.09.2025 13:48 | CODE, NFG, TRX | UK earnings, trading statements calendar - next 7 days | Alliance |
| 22.09.2025 20:20 | GFM, RENX, MSMN | TRADING UPDATES: Mosman Oil and Gas receives "pivotal" bond approval | Alliance |
| 22.09.2025 07:00 | EMVC | Asset Purchase Agreement with Destiny Pharma | RNS |
| 18.09.2025 07:00 | EMVC | Notice of Interim Results | RNS |
| 30.06.2025 12:22 | EMVC | Result of AGM | RNS |
| 30.06.2025 07:00 | EMVC | Office move and Related Party Transaction | RNS |
| 27.06.2025 07:00 | EMVC | Q-Bot Limited Fundraising | RNS |
| 23.06.2025 14:24 | PR1, VLG, TRLS | UK shareholder meetings calendar - next 7 days | Alliance |
| 10.06.2025 13:28 | EMVC | TR-1 | RNS |
| 06.06.2025 15:12 | EMVC | Notice of AGM and Annual Report & Accounts | RNS |
| 04.06.2025 14:34 | EMVC | Director/PDMR Shareholding | RNS |
| 04.06.2025 12:21 | EMVC | EMV Capital loss widens on reduced income but assets rise by third | Alliance |
| 04.06.2025 07:00 | EMVC | Preliminary results for the year ended 31 Dec 2024 | RNS |
| 14.05.2025 16:02 | EMVC | PDS: Q1 Results and Clinical and Corporate Update | RNS |
| 09.05.2025 10:30 | EMVC | TR-1 | RNS |
| 27.03.2025 16:46 | EMVC | PDS: Q4 Results and Clinical Programs Update | RNS |
| 07.03.2025 16:55 | EMVC | EMV Capital investee initiates phase 3 trial for head and neck cancer | Alliance |
| 07.03.2025 16:26 | EMVC | PDS: VERSATILE-003 Phase 3 Clinical Trial | RNS |
| 27.02.2025 16:30 | EMVC | PDS: up to $22mn Registered Direct Offering | RNS |
| 07.02.2025 21:31 | TGR, TRIG, MTL | TRADING UPDATES: T42 IOT Tracking raises funds; Northamber's Dutch buy | Alliance |
| 05.02.2025 15:24 | EMVC | PDS Biotech reaffirms guidance for clinical trial | RNS |
| 03.02.2025 20:06 | EMVC | IN BRIEF: EMV Capital portfolio company ProAxsis plans fundraise | Alliance |
| 03.02.2025 07:00 | EMVC | ProAxsis: Status Update and Proposed Fundraise | RNS |
| 06.01.2025 16:42 | EMVC | TR-1 | RNS |
| 31.12.2024 07:05 | EMVC | Grant of Share Options | RNS |
| 31.12.2024 07:00 | EMVC | Q-Bot Fundraising | RNS |
| 05.12.2024 19:52 | SURE, CLC, EMVC | EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations | Alliance |
| 05.12.2024 07:00 | EMVC | Close of Fundraising and Result of Retail Offer | RNS |
| 03.12.2024 13:24 | EMVC | Result of Subscription | RNS |
| 03.12.2024 07:05 | EMVC | WRAP Retail Offer | RNS |
| 03.12.2024 07:00 | EMVC | Proposed Subscription and Retail Offer; Update | RNS |
| 14.11.2024 15:59 | EMVC | Replacement RNS: PDS: Update, 3rd Quarter Results | RNS |
| 14.11.2024 15:23 | EMVC | PDS: Clinical Programs Update, 3rd Quarter Results | RNS |
| 08.10.2024 07:00 | EMVC | Director/PDMR Shareholding | RNS |
| 03.10.2024 07:00 | EMVC | Director/PDMR Shareholding | RNS |
| 02.10.2024 16:38 | EMVC | PDS: 36-Month Overall Survival Rate announcement | RNS |
| 30.09.2024 07:00 | EMVC | Interim Results | RNS |
| 26.09.2024 07:00 | EMVC | Name change and AIM Rule 26 website | RNS |
